ATB 0,+ ( SLC6A14 ) is a Na + and Cl -dependent amino acid transporter widely distributed in lung, trachea, salivary gland, breast, stomach, eye, hippocampus, intestine, bloodbrain barrier and other tissues
Dietary recommendations are tailored to individual genetic profiles
however, overdose or prolonged use has been associated with toxic effects, primarily affecting the liver and, to a lesser extent, the kidneys [4]
K.ChaabouniS
Ethics declarations Disclosures Katherine Wasden reports receiving the SAGES Medical Student Research Grant
Protocol A: Ultra-Low Start (0.0625 mg to 0.125 mg) This protocol is used for patients who experienced severe GI effects on prior GLP-1 agonist therapy or who have a history of gastroparesis